Men with low-risk prostate cancer have a variety of treatment options because of the relatively benign nature of their disease. Among many factors that influence treatment decisions, the type of cancer center a patient visits is a key one, according to a study led by Yale researchers. Read more read more →

Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer. Although patients with localized, low-risk prostate cancer have treatment options: active surveillance, also called watchful waiting, in which the cancer is monitored periodically to detect any changes, or active treatment.. read more →

Mitchell Sokoloff, MD, chair and professor of urology, will serve as a featured speaker at the First Global Summit on Diagnostic Precision for Prostate Cancer, taking place Sept. 16-18 at the Westin Copley Hotel in Boston. Read more read more →

Ever since inherited mutations in BRCA genes were first linked to breast and ovarian cancer two decades ago, this information has been used as a way to help empower women. Those who have the mutations but don’t yet have cancer can be screened more often or choose to have surgery to remove their breasts and.. read more →

Boston, Jun 16 (PTI) Men suffering from prostate cancer who eat nuts such as almonds, walnuts, cashews and macadamias five or more times a week after diagnosis have a significantly lower risk of mortality than those who consume nuts less than once a month, a new study has claimed. Read more  read more →